Explain this page
Arphra AIPlain-English read on Biogen Inc.’s valuationNext report
upcomingNo forward estimate on file.
Beat streak
0
consecutive EPS beats
Avg surprise
—
trailing 0q
EPS · actual vs estimate
· earnings_historyactualestimate
No earnings history on file.
Forward consensus
No forward annual estimates on file.
Revenue · actual vs estimate ($B)
No revenue estimate history on file.
Reports tracked
24
Beat rate
0%
0 beats · 12 misses (last 12)
Next report
Jul 30, 2026
Est. EPS $3.36
Last report
Apr 29, 2026
Earnings surprises · history
DB · earnings_surprises100% beat2| Period end | Estimate EPS | Actual EPS | Surprise % | Outcome |
|---|---|---|---|---|
| Apr 29, 2026 | $3.05 | $3.57 | +17.05% | Beat |
| Feb 06, 2026 | $1.63 | $1.99 | +22.09% | Beat |
Surprise history (last 16 quarters)
No surprise data available.
Upcoming reports
| Date | EPS estimate | Revenue estimate |
|---|---|---|
| Jul 30, 2026 | $3.36 | $2.43B |
Earnings history
| Date | EPS · est | EPS · actual | Surprise | Revenue · est | Revenue · actual | Result |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | $3.05 | — | — | $2.29B | — | — |
| Feb 06, 2026 | $1.63 | — | — | $2.2B | — | — |
| Oct 30, 2025 | $3.88 | — | — | $2.34B | — | — |
| Jul 31, 2025 | $3.90 | — | — | $2.33B | — | — |
| May 01, 2025 | $2.90 | — | — | $2.23B | — | — |
| Feb 12, 2025 | $3.43 | — | — | $2.41B | — | — |
| Oct 30, 2024 | $3.77 | — | — | $2.43B | — | — |
| Aug 01, 2024 | $4.07 | — | — | $2.39B | — | — |
| Apr 24, 2024 | $3.47 | — | — | $2.31B | — | — |
| Feb 13, 2024 | $3.16 | — | — | $2.47B | — | — |
| Nov 08, 2023 | $3.99 | — | — | $2.39B | — | — |
| Jul 25, 2023 | $3.77 | — | — | $2.37B | — | — |
| Apr 25, 2023 | $3.28 | — | — | $2.34B | — | — |
| Feb 15, 2023 | $3.48 | — | — | $2.45B | — | — |
| Oct 25, 2022 | $4.13 | — | — | $2.47B | — | — |
| Jul 20, 2022 | $4.06 | — | — | $2.47B | — | — |
Analyst estimates · annual
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||
Analyst estimates · quarterly
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||